Talon Therapeutics, Inc. 4
4 · Talon Therapeutics, Inc. · Filed Jul 18, 2013
Insider Transaction Report
Form 4
Furst Howard P.
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2013-07-17−35,000→ 0 totalExercise: $0.77Exp: 2021-04-01→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−10,000→ 0 totalExercise: $0.76Exp: 2020-02-16→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−35,000→ 0 totalExercise: $0.64Exp: 2023-01-25→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−35,000→ 0 totalExercise: $0.91Exp: 2022-02-17→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This stock option was cancelled pursuant to the terms of a Stock Purchase Agreement by and among Talon Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Eagle Acquisition Merger Sub, Inc. dated July 16, 2013.